Navigation Links
New Depakote Marketing Lawsuit on Racketeering: Now, AttorneyOne Can Provide Advice
Date:8/19/2013

San Diego, CA (PRWEB) August 19, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Depakote lawsuits and potential Depakote Recall lawsuit.

As Businessweek published on August 16, a new lawsuit alleges that Abbott engaged in racketeering when it led an effort to market Depakote for unapproved uses (case no. 1:2013cv05865, Illinois Northern District Court). Depakote (valproate) is a drug, manufactured by Abbott Laboratories, most commonly prescribed for psychiatric conditions. According to the article, Abbott last year agreed to pay $1.6 billion to settle claims it promoted Depakote's use to treat bipolar mania and to prevent migraine headaches.

According to court data, on April 29, several plaintiffs filed a lawsuit in Illinois Southern District Court (case no. 3:2013cv00414) alleging serious birth defects caused by their mothers’ ingestion of Depakote during pregnancy. The plaintiffs claim that they were born with “spina bifida, heart defects and neural tube defects, among other congenital malformations and birth defects” because of their mothers’ ingestion of Depakote.

Taking into consideration the latest developments, AttorneyOne.com updated the website and now can actively provide an expert opinion, including how to get in contact with legal counsel easily and inexpensively in case of alleged Depakote serious complications. As Sean Burke, director of Media Relations at AttorneyOne.com, added, “What all this information really illustrates is that the alleged threat from Depakote remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

A new study published on March 6th, in the international neuroscience journal Acta Neurologica Scandinavica, revealed that valproate (Depakote) is linked with birth defects. The results of the study revealed that there were statistically significant associations between valproate exposure and spina bifida, malformations of the heart and great vessels, digits, and skull bones, among others.

AttorneyOne.com has further information on Depakote lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/8/prweb11032555.htm

Read the full story at http://www.prweb.com/releases/2013/8/prweb11037247.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Lawsuit on Serious Birth Defects from Depakote: Now, AttorneyOne Can Provide Advice
2. BMA Management Names Kourtnie Rohrbach as Director of Marketing for St. Anthony of Lansing
3. Liquid Grids Releases Findings from Three Case Studies, Validating Direct to Persona Marketing for Healthcare
4. Inbound Marketing Agency SmartBug Media Further Expands Its Team with New Hire Ben Gallant
5. Ben Altadonna Reveals Profitable Marketing and Life Lessons on Dean Jackson and Joe Polish's "I Love Marketing"...The World's Top Marketing Podcast
6. Personal Trainers Around the Country Learn How to Get More Fitness Boot Camp Clients with the Help of Fitness Marketing Expert, Bedros Keuilian
7. OffWhite Launches Cloud-Based Digital Marketing Platform for Small and Medium Sized Business with Minimal IT Resources
8. DoubleTree Hotel & Executive Meeting Center Palm Beach Gardens Welcomes New Director of Sales & Marketing, Lisa Namour, and presents New Ultimate Meetings Promotion
9. Marketing a New Business: Casey Gollan's Essential Guide
10. Bird-B-Gone, Inc.® Hires New Marketing Specialist
11. SAVA Insurance Group of Connecticut Launches a Custom Virtual Insurance Office as Part of an Innovative Digital Marketing Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... ... already work hand-in-hand on an Innovation Collaboration program, have signed a five-year agreement ... and cost of the care members and patients receive. The agreement also signifies ...
(Date:7/24/2017)... Switzerland (PRWEB) , ... July 24, 2017 , ... Anyone ... to weigh a watermelon, nor would a pharmacist using that same scale to dispense ... risk someone’s health. , These illustrations show why it is important to have ...
(Date:7/24/2017)... ... July 24, 2017 , ... A new report ... on delivering end-to-end sleep health care at scale, indicates record-breaking adherence results for ... rates for positive airway pressure (PAP) therapy, the most widely utilized treatment for ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... prestigious StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with ... StorErotica Awards to be consumer voted. The Magic Wand Rechargeable won in stiff ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality Assurance:, ... **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early bird ... scrutiny and growing demands to track and report adverse events place even greater ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences Inc. ... to support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing ... a leading Chinese Internet services provider, and joined by ... multiple infectious disease product programs targeting antibiotic resistant infections ... Founded by Dr. Rodolphe Barrangou and ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
Breaking Medicine Technology: